Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Oncology

News · December 13, 2022

ASH 2022: Hematopoietic Stem Cell Transplantation Use for AML Remains Low Worldwide, Despite Increasing Rates

Findings indicate low rate persisted in regions dominated by high-resource countries

PracticeUpdate Editorial Team

 

Further Reading